Drug Shortage Report for RATIO-NYSTATIN
Report ID | 1739 |
Drug Identification Number | 02194236 |
Brand name | RATIO-NYSTATIN |
Common or Proper name | NYSTATIN |
Company Name | TEVA CANADA LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | NYSTATIN |
Strength(s) | 100000UNIT |
Dosage form(s) | CREAM |
Route of administration | TOPICAL |
Packaging size | 450GM |
ATC code | D01AA |
ATC description | ANTIFUNGALS FOR TOPICAL USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2016-11-01 |
Estimated end date | |
Actual end date | 2019-05-01 |
Shortage status | Resolved |
Updated date | 2020-02-13 |
Company comments | Product Discontinued. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2020-02-13 | French | Compare |
v4 | 2020-02-13 | English | Compare |
v3 | 2017-03-14 | French | Compare |
v2 | 2017-03-14 | English | Compare |
v1 | 2017-03-13 | English | Compare |
Showing 1 to 5 of 5